FluoGuide A/S Information

FluoGuide is a clinical-stage biotech company specializing in precision cancer surgery. Our mission is to improve outcomes for cancer patients by helping surgeons remove cancer more accurately. Our lead product, FG001, has been clinically proven to light up cancer during surgery, guiding more precise removal while preserving healthy tissue. FG001 has shown strong results in brain, head and neck, and lung cancers, and is well-tolerated by patients. Scientific data and clinical experience suggest its broad potential across solid tumor types. Strategic partnerships with surgical equipment manufacturers support integration and wide adoption of FG001 in the operating room. FluoGuide is listed on the Nasdaq First North Growth Market in Stockholm under the ticker symbol "FLUO." For more information about FluoGuide's pipeline, technology, and upcoming events, visit www.fluoguide.com.

Website	https://fluoguide.com
Revenue	$9.3 million
Employees	15 (6 on RocketReach)
Founded	2018
Phone	+45 31 31 43 73
Technologies	JavaScript , HTML , PHP +15 more (view full list)
Industry	Biotechnology, Medical Devices & Equipment, Manufacturing
Keywords	Surgical Oncology, Image Guided Surgery, Medical Imaging Technology, Surgical Guidance, Biotech, Oncology, Minimal Invasive Surgery, Cancer Diagnostics, Medical Devices, Surgical Illumination, Cancer Therapeutics, Molecular Imaging
Competitors	Exact Sciences, Daiichi Sankyo, Inc., Siemens, Novartis, Roche, Philips, Medtronic, GE HealthCare, Agendia, Foundation Medicine +36 more (view full list)
SIC	SIC Code 38 Companies, SIC Code 80 Companies
NAICS	NAICS Code 33 Companies, NAICS Code 339 Companies